» Articles » PMID: 32698868

Therapeutic Applications of Adipose Cell-free Derivatives: a Review

Overview
Publisher Biomed Central
Date 2020 Jul 24
PMID 32698868
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Adipose-derived stem cells (ADSCs) have become one of the most utilized adult stem cells due to their abundance and accessibility. Recent studies have shown that paracrine cytokines, exosomes, and other active substances are the main factors through which ADSCs exert their biological effects.

Main Body: Adipose cell-free derivatives have been recently gaining attention as potential therapeutic agents for various human diseases. These derivatives include ADSC-conditioned medium (ADSC-CM), ADSC exosomes (ADSC-Exo), and cell-free adipose tissue extracts (ATEs), all of which can be conveniently carried, stored, and transported. Currently, research on ADSC-conditioned medium (ADSC-CM) and ADSC exosomes (ADSC-Exo) is surging. Moreover, cell-free adipose tissue extracts (ATEs), obtained by purely physical methods, have emerged as the focus of research in recent years.

Conclusion: Adipose cell-free derivatives delivery can promote cell proliferation, migration, and angiogenesis, suppress cell apoptosis, and inflammation, as well as reduce oxidative stress and immune regulation. Thus, adipose cell-free derivatives have a broad therapeutic potential in many areas, as they possess anti-skin aging properties, promote wound healing, reduce scar formation, and provide myocardial protection and neuroprotection. This article summarizes these effects and reviews research progress in the use of adipose cell-free derivatives.

Citing Articles

Adipose-derived stem cells using fibrin gel as a scaffold enhances post-hepatectomy liver regeneration.

Imamura H, Tomimaru Y, Kobayashi S, Harada A, Kita S, Sasaki K Sci Rep. 2025; 15(1):6334.

PMID: 39984656 PMC: 11845764. DOI: 10.1038/s41598-025-90805-7.


Growth factors IGF-1 and KGF and adipose-derived stem cells promote migration and viability of primary human keratinocytes in an wound model.

Stadelmann N, Horch R, Schmid R, Ostendorf D, Peddi A, Promny T Front Med (Lausanne). 2025; 12:1516116.

PMID: 39981084 PMC: 11839819. DOI: 10.3389/fmed.2025.1516116.


Application of multi-needle injector for delivering human adipose stem cells to combat photoaging in nude mice.

Li T, Wang S, Zhang D, Jiang H Arch Dermatol Res. 2025; 317(1):407.

PMID: 39951144 DOI: 10.1007/s00403-025-03936-2.


The Effect of Human Adipose Stem Cell-Conditioned Medium (hASC-CM) in Photoaged Skin.

Putri W, Widyaswari M, Prakoeswa C, Muhammad D, Romadhani D, Nisaussholihah N J Stem Cells Regen Med. 2025; 20(2):47-52.

PMID: 39845504 PMC: 11750066. DOI: 10.46582/jsrm.2002006.


Adipose Mesenchymal Stem Cell-Derived Exosomes as Nanocarriers for Treating Musculoskeletal Disorders.

Tang A, Shu Q, Jia S, Lai Z, Tian J Int J Nanomedicine. 2024; 19:13547-13562.

PMID: 39720215 PMC: 11668248. DOI: 10.2147/IJN.S486622.


References
1.
Yang C, Luo L, Bai X, Shen K, Liu K, Wang J . Highly-expressed micoRNA-21 in adipose derived stem cell exosomes can enhance the migration and proliferation of the HaCaT cells by increasing the MMP-9 expression through the PI3K/AKT pathway. Arch Biochem Biophys. 2020; 681:108259. DOI: 10.1016/j.abb.2020.108259. View

2.
Li Y, Zhang W, Gao J, Liu J, Wang H, Li J . Adipose tissue-derived stem cells suppress hypertrophic scar fibrosis via the p38/MAPK signaling pathway. Stem Cell Res Ther. 2016; 7(1):102. PMC: 4970202. DOI: 10.1186/s13287-016-0356-6. View

3.
Squillaro T, Peluso G, Galderisi U . Clinical Trials With Mesenchymal Stem Cells: An Update. Cell Transplant. 2015; 25(5):829-48. DOI: 10.3727/096368915X689622. View

4.
Liu Z, Xu Y, Wan Y, Gao J, Chu Y, Li J . Exosomes from adipose-derived mesenchymal stem cells prevent cardiomyocyte apoptosis induced by oxidative stress. Cell Death Discov. 2019; 5:79. PMC: 6425027. DOI: 10.1038/s41420-019-0159-5. View

5.
Rathinasabapathy A, Bruce E, Espejo A, Horowitz A, Sudhan D, Nair A . Therapeutic potential of adipose stem cell-derived conditioned medium against pulmonary hypertension and lung fibrosis. Br J Pharmacol. 2016; 173(19):2859-79. PMC: 5275771. DOI: 10.1111/bph.13562. View